Dual Mobility Acetabular Cups in Revision TJA

Sponsor
Rush University Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT04090359
Collaborator
Rothman Institute Orthopaedics (Other), NYU Langone Health (Other)
322
2
2
300
161
0.5

Study Details

Study Description

Brief Summary

The aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobility components in revision THA will be associated with a lower dislocation rate in the first year following surgery.

Condition or Disease Intervention/Treatment Phase
  • Device: Dual Mobility Implant
  • Device: Conventional, single-bearing implant
Phase 4

Detailed Description

The aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobility components in revision THA will be associated with a lower dislocation rate in the first year following surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
322 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trial with two groups: revision THA with dual mobility components vs revision THA with large head, single bearing designs (36mm and 40mm).Randomized controlled trial with two groups: revision THA with dual mobility components vs revision THA with large head, single bearing designs (36mm and 40mm).
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Dual Mobility Acetabular Cups in Revision TJA
Actual Study Start Date :
Sep 1, 2017
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2042

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dual Mobility

If patients are randomized to the dual mobility cohort, they will receive a dual mobility prosthesis at the surgeon's discretion. All surgeries will be performed via the posterior approach, per the participating surgeon's usual standard. Patients will be on postoperative hip precautions for 6 weeks, per departmental protocol. No braces will be utilized.

Device: Dual Mobility Implant
Patients in this intervention will receive a dual mobility implant

Active Comparator: Conventional, Single-bearing hip implant

If patients are randomized to the conventional, single bearing cohort, surgeons will use their preferred implant design at their discretion using a 36 or 40mm head, depending on the diameter of the cup and manufacturer specifications. All surgeries will be performed via the posterior approach, per the participating surgeon's usual standard. Patients will be on postoperative hip precautions for 6 weeks, per departmental protocol. No braces will be utilized.

Device: Conventional, single-bearing implant
Patients in this intervention will receive a conventional, single-bearing implant

Outcome Measures

Primary Outcome Measures

  1. Prosthetic Dislocation [6 weeks]

    The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits

  2. Prosthetic Dislocation [3 months]

    The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits

  3. Prosthetic Dislocation [2 years]

    The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits

  4. Prosthetic Dislocation [5 years]

    The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits

  5. Prosthetic Dislocation [10 years]

    The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits

  6. Prosthetic Dislocation [15 years]

    The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits

  7. Prosthetic Dislocation [20 years]

    The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits

Secondary Outcome Measures

  1. Complications [up to 20 years after the patient is discharged from the hospital]

    Any peri- or postoperative complications will be recorded, including component loosening, occurrence of intraprosthetic dislocation, infection, periprosthetic fractures, revision rates

  2. Routine radiographs assess for loosening and proper component placement [6 weeks]

    Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.

  3. Routine radiographs assess for loosening and proper component placement [3 months]

    Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.

  4. Routine radiographs assess for loosening and proper component placement [2 years]

    Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.

  5. Routine radiographs assess for loosening and proper component placement [5 years]

    Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.

  6. Routine radiographs assess for loosening and proper component placement [10 years]

    Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.

  7. Routine radiographs assess for loosening and proper component placement [15 years]

    Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.

  8. Routine radiographs assess for loosening and proper component placement [20 years.]

    Routine radiographs (AP Pelvis, frogleg lateral, and cross-table lateral radiographs) will be obtained at follow-up visits and assessed for cup placement, anteversion, radiographic signs of loosening, and component migration. Radiographics will be assessed for loosening in a yes/no way.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Any patient older than 18 years of age scheduled for a revision THA, including revision of both components, conversion of a hip resurfacing to THA, conversion of a hemiarthroplasty to THA, and revision of single components which allow implantation of dual-mobility bearings. In addition, patients undergoing reimplantation of a total hip arthroplasty following a two-stage revision for periprosthetic infection will also be included. Only patients with an acetabular shell diameter capable of accommodating at least a 36mm femoral head will be included.
Exclusion Criteria:
  • Less than 18 years of age, primary THA,

  • conversion of non-arthroplasty femoral neck fracture fixation to THA,

  • patients unwilling to participate.

  • patients where the surgeon makes the intraoperative decision to use a constrained liner will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York University Medical Center New York New York United States 10003
2 Rothman Institute Philadelphia Pennsylvania United States 19107

Sponsors and Collaborators

  • Rush University Medical Center
  • Rothman Institute Orthopaedics
  • NYU Langone Health

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rush University Medical Center
ClinicalTrials.gov Identifier:
NCT04090359
Other Study ID Numbers:
  • 17022801
First Posted:
Sep 16, 2019
Last Update Posted:
Aug 23, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 23, 2021